Human chorionic gonadotropin biosimilar (BioGeneric Pharma)

人绒毛膜促性腺激素生物类似药 (BioGeneric Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman chorionic gonadotropin biosimilar (BioGeneric Pharma)

Drug Alias Name人绒毛膜促性腺激素生物仿制药 (BioGeneric Pharma)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar

Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsOvarian follicle stimulants

TargetsLuteinizing hormone/Choriogonadotropin receptor

Therapy Area/IndicationsInfertility

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiogeneric Pharma

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsInfertility

Inactive IndicationsN/A

ATC CodeG03GA08